MY ACCOUNT | NEWSLETTER |

SARS-CoV-2 infection in a cat and three dogs living in households with humans positive for COVID-19


A team of researchers from the Complutense University of Madrid made up of Guadalupe Miró, Javier Regidor-Cerrillo, Rocío Checa, Carlos Diezma-Díaz, Ana Montoya, Jesús García-Cantalejo, Pedro Botías, Javier Arroyo and Luis-Miguel Ortega-Mora, have recently published a study tracking a cat and three dogs living in COVID-19 positive households.

To date, the total number of PCR-positive domestic dogs and cats worldwide is 102 and 86, respectively. However, only a low percentage of viral detection (<10%) has been confirmed by sequencing. This study describes the dynamics of SARS-CoV-2 infection in three dogs (two with mild respiratory signs) and one cat (with severe secondary pneumonia) from households with confirmed human cases of COVID-19 living in the community. Madrid at the time of the expansion of the SARS-CoV-2 alpha variant (lineage B.1.1.7).

Sampling

To do this, they underwent a complete physical examination and nasopharyngeal, oropharyngeal, and rectal swabs to perform real-time reverse transcription PCR (RT-qPCR) for the detection of SARS-CoV-2 on day 0 and in successive samples on days 7, 14, 21 and 47 during follow-up. Blood was also drawn for complete blood counts, biochemical profiles, and serology of the IgG response against SARS-CoV-2.

On day 0, the cat in case 1 presented with dyspnea and fever associated with a mild bronchoalveolar pattern. The dogs in Cases 2, 3, and 4 were healthy, but Case 2 developed cough, dyspnea, and weakness, and Case 4 developed a cough and bilateral nasal discharge 3 and 6 days prior to clinical examination. Case 3 (from the same household as case 2) remained asymptomatic.

Alpha variant

Detection of SARS-CoV-2 by RT-qPCR showed that cat case 1 and dog case 2 exhibited the lowest cycle threshold (Ct) (Ct < 30) when presenting with clinical signs. Viral detection failed in successive samplings. Serologic tests revealed a positive IgG response in cat cases 1 and dog cases 3 and 4 shortly after or simultaneously with virus shedding. Dog case 2 was seronegative but seroconverted 21 days after detection of SARS-CoV-2. SARS-CoV-2 genome sequencing was performed, and the genomes were classified as belonging to the B.1.1.7 lineage.

Conclusion

The findings support the theory of SARS-CoV-2 infection in cats and dogs from COVID-19-positive households as a reverse zoonosis. The only cat in this study and two of the three RT-qPCR-positive dogs showed respiratory clinical signs that were milder in the dog cases. All of them seroconverted shortly after detection of infection in their owners. Viral sequencing in all cases identified the B.1.1.7. variant, which was predominant in human cases in this Spanish region at the time of sampling. Further studies are needed to elucidate how the new variants are changing the epidemiological scenario in COVID-19-positive households with pets.

Guadalupe Miró, Javier Regidor-Cerrillo, Rocio Checa, Carlos Diezma-Díaz, Ana Montoya, Jesús García-Cantalejo, Pedro Botías, Javier Arroyo and Luis-Miguel Ortega-Mora. SARS-CoV-2 Infection in One Cat and Three Dogs Living in COVID-19-Positive Households in Madrid, Spain. Front. Vet. Sci., 10 November 2021 | https://doi.org/10.3389/fvets.2021.779341

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top